How severe is CVE-2020-27268?

CVE-2020-27268 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.

Is CVE-2020-27268 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (41st percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2020-27268?

CVE-2020-27268 primarily affects Sooil Anydana-a Firmware. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2020-27268?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2020-27268 published?

CVE-2020-27268 was published on 2021-01-19 and last updated on 2026-06-17.

CVE-2020-27268

CVE-2020-27268 is a medium-severity vulnerability in Sooil Anydana-a Firmware with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-669.

Key facts

Severity: Medium (CVSS 3.x base score 6.5)
CVSS v2: 3.3
EPSS exploit prediction: 1% (41st percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-669
Affected product: Sooil Anydana-a Firmware
Published: 2021-01-19
Last modified: 2026-06-17

Description

In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass checks for default PINs via Bluetooth Low Energy.

Frequently asked questions

What is CVE-2020-27268?: In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass checks for default PINs via Bluetooth Low Energy.
How severe is CVE-2020-27268?: CVE-2020-27268 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2020-27268 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (41st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2020-27268?: CVE-2020-27268 primarily affects Sooil Anydana-a Firmware. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2020-27268?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2020-27268 published?: CVE-2020-27268 was published on 2021-01-19 and last updated on 2026-06-17.

References

https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01

Affected products (3)

cpe:2.3:o:sooil:anydana-a_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:sooil:anydana-i_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:sooil:diabecare_rs_firmware:*:*:*:*:*:*:*:*

More vulnerabilities in Sooil Anydana-a Firmware

CVE-2020-27264 — High (CVSS 8.8): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump…
CVE-2020-27256 — Medium (CVSS 6.8): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a hard-coded physician PIN in the physician menu…
CVE-2020-27266 — Medium (CVSS 6.5): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the…
CVE-2020-27269 — Medium (CVSS 5.7): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump…
CVE-2020-27276 — Medium (CVSS 5.7): SOOIL Developments Co Ltd DiabecareRS,AnyDana-i & AnyDana-A, the communication protocol of the insulin pump and its…
CVE-2020-27272 — Medium (CVSS 5.7): SOOIL Developments CoLtd DiabecareRS, AnyDana-i, AnyDana-A, The communication protocol of the insulin pump and…

All CVEs affecting Sooil Anydana-a Firmware →

Other CWE-669 vulnerabilities

CVE-2021-30120 — Critical (CVSS 9.9): Kaseya VSA before 9.5.7 allows attackers to bypass the 2FA requirement. The need to use 2FA for authentication in…
CVE-2025-67895 — Critical (CVSS 9.8): Edge3 Worker RPC RCE on Airflow 2. This issue affects Apache Airflow Providers Edge3: before 2.0.0 - and only if you…
CVE-2022-4446 — Critical (CVSS 9.8): PHP Remote File Inclusion in GitHub repository tsolucio/corebos prior to 8.0.
CVE-2020-24683 — Critical (CVSS 9.8): The affected versions of S+ Operations (version 2.1 SP1 and earlier) used an approach for user authentication which…
CVE-2020-5800 — Critical (CVSS 9.8): The Eat Spray Love mobile app for both iOS and Android contains logic that allows users to bypass authentication and…
CVE-2020-15892 — Critical (CVSS 9.8): An issue was discovered in apply.cgi on D-Link DAP-1520 devices before 1.10b04Beta02. Whenever a user performs a login…

Browse all CWE-669 vulnerabilities →